Abstract:Non‐alcoholic fatty liver disease (NAFLD) is an essential component of metabolic syndrome. Much evidence has demonstrated that the incidence of NAFLD is markedly increased in obese populations. In addition, adiposity and inflammation are two factors that critically contribute to the development and progression of hepatic steatosis and inflammatory damage in obesity‐associated NAFLD. While mediating the anti‐inflammatory activity of adenosine, the 2A receptor of adenosine (A2AR) also has a protective role in NAFLD. However, it remains largely unknown about the extent to which A2AR acts through altering adiposity vs. inflammation to protect against NAFLD. In the present study, the effects of A2AR deficiency on aspects of NAFLD were investigated in both obese mice and lean mice upon feeding wild‐type (WT) C57BL/6J mice and A2AR‐deficent mice a high‐fat diet (HFD) and/or a methionine‐ and choline‐deficient diet (MCD). Compared with low‐fat diet‐fed mice, HFD‐fed WT mice displayed overt hepatic steatosis and inflammation as indicated by increased proinflammatory signaling and cytokine expression. Furthermore, the severity of HFD‐induced hepatic steatosis and inflammation in A2AR‐deficient mice was much greater than that in WT mice, which was accompanied with increased body weight, adiposity, and adipose tissue infiltration of proinflammatory macrophages in HFD‐fed A2AR‐deficient mice. Unlike HFD‐fed mice, all MCD‐fed mice displayed lean phenotype due to a significant decrease in food intake. In the absence of adiposity, A2AR‐deficient mice still displayed a greater increase in the severity of hepatic steatosis and inflammation compared with WT mice. In an in vitro system, A2AR‐deficient macrophages showed an increase in proinflammatory responses compared with control cells. In addition, co‐culture of WT primary mouse hepatocytes with A2AR‐deficient macrophages caused significant increases in hepatocyte fat deposition and in hepatocyte proinflammatory responses compared with WT hepatocyte‐macrophage co‐cultures. Taken together, these results suggest that A2AR‐defiency‐associated inflammation is sufficient enough to bring about NAFLD aspects although A2AR deficiency can act through increasing both adiposity and inflammation to exacerbate NAFLD. Therefore, A2AR appears to protect against NAFLD mainly through its anti‐inflammatory activity.

Deficiency of ADAR2 ameliorates metabolic-associated fatty liver disease via AMPK signaling pathways in obese mice

ADAR2 deficiency ameliorates non‐alcoholic fatty liver disease and muscle atrophy through modulating serum amyloid A1

Exercise-Induced ADAR2 Protects against Nonalcoholic Fatty Liver Disease through miR-34a.

Exacerbation of NAFLD in Both HFD‐fed Mice and MCD‐fed Mice by Adenosine 2A Receptor Deficiency

AMPD2 plays important roles in regulating hepatic glucose and lipid metabolism

Adipose ADM2 ameliorates NAFLD via promotion of ceramide catabolism

Disruption of Adenosine 2A Receptor Exacerbates NAFLD Through Increasing Inflammatory Responses and SREBP1c Activity

ADAR1 Deficiency Protects Against High-Fat Diet-Induced Obesity and Insulin Resistance in Mice.

P2Y2R Deficiency Ameliorates Hepatic Steatosis by Reducing Lipogenesis and Enhancing Fatty Acid β-Oxidation through AMPK and PGC-1α Induction in High-Fat Diet-Fed Mice

Exploration and Validation of Ferroptosis-Associated Genes in ADAR1 Deletion-Induced NAFLD through RNA-seq Analysis

Genetic Deletion of Β2 Adrenergic Receptors Exacerbates Hepatocellular Lipid Accumulation in High-Fat Diet Mice.

CSAD Ameliorates Lipid Accumulation in High-Fat Diet-Fed Mice

Mice lacking adenosine 2A receptor reveal increased severity of MCD-induced NASH.

Hepatocyte Adenosine Kinase Promotes Excessive Fat Deposition and Liver Inflammation

The Role of AMPKα2 in the HFD-induced Nonalcoholic Steatohepatitis.

MD2 deficiency prevents high‐fat diet‐induced AMPK suppression and lipid accumulation through regulating TBK1 in non‐alcoholic fatty liver disease

Adenosine deaminase 2 produced by infiltrative monocytes promotes liver fibrosis in nonalcoholic fatty liver disease

Rab2A regulates the progression of nonalcoholic fatty liver disease downstream of AMPK-TBC1D1 axis by stabilizing PPARγ

Extracellular Superoxide Dismutase Attenuates Hepatic Oxidative Stress in Nonalcoholic Fatty Liver Disease through the Adenosine Monophosphate-Activated Protein Kinase Activation

Genetic Liver-Specific AMPK Activation Protects against Diet-Induced Obesity and NAFLD

ADAR1 plays a protective role in proximal tubular cells under high glucose conditions by attenuating the PI3K/AKT/mTOR signaling pathway